A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Mats Heyman
6,430 participants
Jul 13, 2020
INTERVENTIONAL
Conditions
Summary
ALLTogether collects the experience of previously successful treatment of infants, children and young adults, with ALL from a number of well-renowned study groups into a new master protocol, which is both a comprehensive system for stratification and treatment of ALL in this age-group as well as the basis for several randomised and interventional trials included in the study-design.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Omission of IV Doxorubicin
Omission of Vincristine+Dexamethasone pulses
Addition of IV Inotuzumab ozogamicin before Maintenance Therapy
p.o. Imatinib
Addition of p.o. 6-tioguanine to Standard Maintenance Therapy
IV Blinatumomab
Locations(139)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04307576